121 related articles for article (PubMed ID: 12217758)
41. Combination of HIFU therapy with contrast-enhanced sonography for quantitative assessment of therapeutic efficiency on tumor grafted mice.
Rouffiac V; Duret JS; Péronneau P; Dehez N; Opolon P; Roche A; Lassau N
Ultrasound Med Biol; 2006 May; 32(5):729-40. PubMed ID: 16677932
[TBL] [Abstract][Full Text] [Related]
42. [Effects of hypoxia inducible factor-2α on promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation].
Wu L; Zhou W; Zhou S; Liu C; Li S
Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):112-7. PubMed ID: 25880977
[TBL] [Abstract][Full Text] [Related]
43. Recurrence of uterine leiomyosarcoma 25 years after therapy.
Gallup DG; Hobbs LH; Ross WB
Gynecol Oncol; 1982 Jun; 13(3):293-300. PubMed ID: 7095568
[No Abstract] [Full Text] [Related]
44. Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound.
Häcker A; Michel MS; Marlinghaus E; Köhrmann KU; Alken P
BJU Int; 2006 Apr; 97(4):779-85. PubMed ID: 16536773
[TBL] [Abstract][Full Text] [Related]
45. Clinical and future applications of high intensity focused ultrasound in cancer.
Al-Bataineh O; Jenne J; Huber P
Cancer Treat Rev; 2012 Aug; 38(5):346-53. PubMed ID: 21924838
[TBL] [Abstract][Full Text] [Related]
46. Non-invasive therapeutic use of High-Intensity Focused Ultrasound (HIFU) with 3 Tesla Magnetic Resonance Imaging in women with symptomatic uterine fibroids.
Łoziński T; Filipowska J; Gurynowicz G; Gabriel I; Czekierdowski A
Ginekol Pol; 2017; 88(9):497-503. PubMed ID: 29057436
[TBL] [Abstract][Full Text] [Related]
47. High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma.
Yu W; Tang L; Lin F; Yao Y; Shen Z; Zhou X
Surg Oncol; 2015 Mar; 24(1):9-15. PubMed ID: 25453577
[TBL] [Abstract][Full Text] [Related]
48. [High-intensity focused ultrasound (HIFU) for tumor pain relief in inoperable pancreatic cancer : Evaluation with the pain sensation scale (SES)].
Marinova M; Strunk HM; Rauch M; Henseler J; Clarens T; Brüx L; Dolscheid-Pommerich R; Conrad R; Cuhls H; Radbruch L; Schild HH; Mücke M
Schmerz; 2017 Feb; 31(1):31-39. PubMed ID: 27402264
[TBL] [Abstract][Full Text] [Related]
49. Rodent model of reproductive tract leiomyomata: characterization and use in preclinical therapeutic studies.
Howe SR; Everitt JL; Gottardis MM; Walker C
Prog Clin Biol Res; 1997; 396():205-15. PubMed ID: 9108599
[No Abstract] [Full Text] [Related]
50. High intensity focused ultrasound inhibits melanoma cell migration and metastasis through attenuating microRNA-21-mediated PTEN suppression.
Li H; Yuan SM; Yang M; Zha H; Li XR; Sun H; Duan L; Gu Y; Li AF; Weng YG; Luo JY; He TC; Wang Y; Li CY; Li FQ; Wang ZB; Zhou L
Oncotarget; 2016 Aug; 7(31):50450-50460. PubMed ID: 27391071
[TBL] [Abstract][Full Text] [Related]
51. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor].
Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931
[No Abstract] [Full Text] [Related]
52. Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy.
Ziebarth AJ; Felder MA; Harter J; Connor JP
Cancer Immunol Immunother; 2012 Jul; 61(7):1149-53. PubMed ID: 22562378
[TBL] [Abstract][Full Text] [Related]
53. [An experimental study on high intensity focused ultrasound combined with mitomycin treatment of bladder tumor].
Wang GM; Yang YF; Sun LA; Xu ZB; Xu YQ
Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):897-900. PubMed ID: 14728828
[TBL] [Abstract][Full Text] [Related]
54. [Relapsing uterine leiomyosarcoma: report of a case].
Benabdejlil Y; Elmarjany M; Babahabib A; Elhassani M; Chahdi H; Kouach J; Moussaoui DR; Dehayni M
Pan Afr Med J; 2014; 19():74. PubMed ID: 25709732
[TBL] [Abstract][Full Text] [Related]
55. [Experimental study of the therapeutic effects of an anti-endothelial cell monoclonal antibody BVE-1 for solid tumor xenograft in nude mice].
Li P; Yuan M; Xia H
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):280-3. PubMed ID: 10920984
[TBL] [Abstract][Full Text] [Related]
56. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.
Hu Z; Yang XY; Liu Y; Sankin GN; Pua EC; Morse MA; Lyerly HK; Clay TM; Zhong P
J Transl Med; 2007 Jul; 5():34. PubMed ID: 17625013
[TBL] [Abstract][Full Text] [Related]
57. Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.
Parsons JE; Lau MPH; Martin PJ; Islas Lagos JJ; Aguilar Aguirre JM; Garza Leal JG
J Minim Invasive Gynecol; 2017; 24(4):579-591. PubMed ID: 28109895
[TBL] [Abstract][Full Text] [Related]
58. Clinical utility of a microbubble-enhancing contrast ("SonoVue") in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study.
Peng S; Xiong Y; Li K; He M; Deng Y; Chen L; Zou M; Chen W; Wang Z; He J; Zhang L
Eur J Radiol; 2012 Dec; 81(12):3832-8. PubMed ID: 22613505
[TBL] [Abstract][Full Text] [Related]
59. Spleen hemostasis using high-intensity ultrasound: survival and healing.
Noble ML; Vaezy S; Keshavarzi A; Paun M; Prokop AF; Chi EY; Cornejo C; Sharar SR; Jurkovich GJ; Martin RW; Crum LA
J Trauma; 2002 Dec; 53(6):1115-20. PubMed ID: 12478037
[TBL] [Abstract][Full Text] [Related]
60. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T
Yang S; Kong F; Hou R; Rong F; Ma N; Li S; Yang J
Br J Radiol; 2017 May; 90(1073):20160760. PubMed ID: 28256923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
